Literature DB >> 31149280

CARDIOVASCULAR RISK FACTORS IN ADOLESCENTS: ROLE OF INSULIN RESISTANCE AND OBESITY.

J Lopez-Sandoval1, S Sanchez-Enriquez2, E A Rivera-Leon2, B E Bastidas-Ramirez2, M R Garcia-Garcia3, M E Gonzalez-Hita2.   

Abstract

INTRODUCTION: Childhood obesity is a public health problem characterized by early insulin resistance (IR), inflammation, and oxidative stress. The presence of an uninterrupted low-grade inflammatory state impairs metabolic and cardiovascular health. The population is particularly susceptible to develop metabolic disorders related to increased body fat.
METHODS: Eighty-three adolescents were recruited and grouped according to HOMA-IR and BMI in either with or without IR and obese or normal-weight respectively. Anthropometric, biochemical, immunological and hormonal variables were determined. Transverse Analytical Study.
RESULTS: Obesity, dyslipidemia, IL-6, and C-reactive protein were significantly higher in the IR group than in the non-IR group. Obese adolescents showed increased insulin levels, HOMA-IR, inflammatory markers, and triglycerides; while having lower HDL-C, and adiponectin when compared to normal-weight adolescents. As expected, obesity-related anthropometric markers positively correlated with IR and inflammatory markers while negatively correlated with adiponectin levels.
CONCLUSIONS: Early IR, subclinical inflammation, dyslipidemia, and hypoadiponectinemia characterize obesity in adolescents. These factors may increase the risk of future coronary heart disease (CHD) and diabetes mellitus development (DM) in early adulthood.

Entities:  

Keywords:  adiponectin; adolescents; body fat; cardiovascular risk; obesity

Year:  2018        PMID: 31149280      PMCID: PMC6525782          DOI: 10.4183/aeb.2018.330

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  34 in total

Review 1.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Low adiponectin levels predict type 2 diabetes in Mexican children.

Authors:  Miguel Cruz; Rebeca García-Macedo; Yolanda García-Valerio; Margarita Gutiérrez; Rafael Medina-Navarro; Genoveva Duran; Niels Wacher; Jesús Kumate
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

3.  Increased oxidative stress in obesity and its impact on metabolic syndrome.

Authors:  Shigetada Furukawa; Takuya Fujita; Michio Shimabukuro; Masanori Iwaki; Yukio Yamada; Yoshimitsu Nakajima; Osamu Nakayama; Makoto Makishima; Morihiro Matsuda; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

5.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

Authors:  J S Yudkin; C D Stehouwer; J J Emeis; S W Coppack
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

Review 6.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

Authors:  G Boden; G I Shulman
Journal:  Eur J Clin Invest       Date:  2002-06       Impact factor: 4.686

7.  Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children.

Authors:  Kohtaro Asayama; Hidemasa Hayashibe; Kazushige Dobashi; Norihiko Uchida; Takaya Nakane; Kohji Kodera; Akira Shirahata; Matsuo Taniyama
Journal:  Obes Res       Date:  2003-09

8.  Plasma adiponectin concentrations in children: relationships with obesity and insulinemia.

Authors:  Norbert Stefan; Joy C Bunt; Arline D Salbe; Tohru Funahashi; Yuji Matsuzawa; P Antonio Tataranni
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

9.  The high prevalence of overweight and obesity in Mexican children.

Authors:  Blanca E del Río-Navarro; Oscar Velázquez-Monroy; Claudia P Sánchez-Castillo; Agustín Lara-Esqueda; Arturo Berber; Guillermo Fanghänel; Rafael Violante; Roberto Tapia-Conyer; W Philip T James
Journal:  Obes Res       Date:  2004-02

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  2 in total

1.  Independent predictors of insulin resistance in Brazilian adolescents: Results of the study of cardiovascular risk in adolescents-Brazil.

Authors:  Maria Izabel Siqueira de Andrade; Juliana Souza Oliveira; Vanessa Sá Leal; Poliana Coelho Cabral; Pedro Israel Cabral de Lira
Journal:  PLoS One       Date:  2021-02-09       Impact factor: 3.240

2.  Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD).

Authors:  Gopi Battineni; Getu Gamo Sagaro; Nalini Chintalapudi; Francesco Amenta; Daniele Tomassoni; Seyed Khosrow Tayebati
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.